Home
AbbVie ABBV spent $1.5M on lobbying in Q1 2023 · Medicare, Taxation and 2 more issues
Trade details
- Type
- Lobbying report
- Amount
- $1,500,000
- Quarter
- Q1 2023
- Stock
- AbbVie ABBV
- Client
- Abbvie
- Reported
- 23/04/20
Up 54.6% from last quarter
What else happened in AbbVie around then
Filed or reported within 30 days of the trade day · 23/03/01~23/04/30Abbvie's other lobbying reports
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$50K
$50K
Reported 07/20
for Q2
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$60K
$60K
Reported 07/20
for Q2
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$1.2M
$1.2M
Reported 07/20
for Q2
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$60K
$60K
Reported 07/20
for Q2
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$30K
$30K
Reported 07/20
for Q2